Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial

IMPORTANCE: Amyloid positron emission tomography (PET) allows the direct assessment of amyloid deposition, one of the main hallmarks of Alzheimer disease. However, this technique is currently not widely reimbursed because of the lack of appropriately designed studies demonstrating its clinical effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Altomare, Daniele, Barkhof, Frederik, Caprioglio, Camilla, Collij, Lyduine E., Scheltens, Philip, Lopes Alves, Isadora, Bouwman, Femke, Berkhof, Johannes, van Maurik, Ingrid S., Garibotto, Valentina, Moro, Christian, Delrieu, Julien, Payoux, Pierre, Saint-Aubert, Laure, Hitzel, Anne, Molinuevo, José Luis, Grau-Rivera, Oriol, Gispert, Juan Domingo, Drzezga, Alexander, Jessen, Frank, Zeyen, Philip, Nordberg, Agneta, Savitcheva, Irina, Jelic, Vesna, Walker, Zuzana, Edison, Paul, Demonet, Jean-François, Gismondi, Rossella, Farrar, Gill, Stephens, Andrew W., Frisoni, Giovanni B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167601/
https://www.ncbi.nlm.nih.gov/pubmed/37155177
http://dx.doi.org/10.1001/jamaneurol.2023.0997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167601/
https://www.ncbi.nlm.nih.gov/pubmed/37155177
http://dx.doi.org/10.1001/jamaneurol.2023.0997

Ejemplares similares